查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790345

美國大規模和小規模生物加工市場規模、佔有率和趨勢分析報告：按規模、工作流程、產品、應用、使用類型、模式和細分預測，2025-2033 年

U.S. Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Scale, By Workflow, By Product (Bioreactors/Fermenters, Cell Culture Products), By Application, By Use-Type, By Mode, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國大規模和小規模生物加工市場概況

預計 2024 年美國大規模和小規模生物加工市場價值將達到 248.6 億美元，到 2033 年將達到 673.4 億美元，2025 年至 2033 年的複合年成長率為 11.24%。這一成長是由全球對單株抗體、疫苗以及細胞和基因療法等生技藥品日益成長的需求所推動的。

生物製藥公司擴大投資於靈活的製造解決方案，例如一次性技術和模組化生物製程系統，以縮短開發時間並降低成本。

美國生物加工領域擴大採用一次性技術

一次性技術 (SUT) 的日益普及正在改變美國大規模和小規模生物加工市場，使其在生技藥品生產中實現更高的靈活性、業務效率和成本效益。一次性系統（包括反應器、袋子、過濾器、連接器和管道）比傳統的不銹鋼裝置越來越受歡迎，尤其是在小批量、高混合度的生產設施中。它們能夠減少清洗驗證、降低交叉污染風險並最大程度地縮短週轉時間，非常適合現代快節奏的生物生產環境。隨著個人化醫療和模組化製造需求的不斷成長，SUT 在臨床和商業階段的應用都在加速。

生物製藥公司和CDMO正在利用一次性技術來簡化放大流程、縮短開發時間，並滿足日益成長的敏捷生產需求。這些系統在早期製造階段尤其重要，因為靈活性和速度至關重要。細胞和基因療法通常需要小批量、高價值的生產，而這種成長進一步推動了向基於一次性技術 (SUT) 的基礎設施的轉變。此外，多產品生產設施的興起需要快速切換，與傳統的就地清洗系統相比，一次性組件可以更有效率地滿足這項需求。

生物加工設備製造商在SUT領域不斷創新，以提升性能、耐用性以及與複雜生技藥品的兼容性。 γ穩定聚合物、自動化整合系統和可擴展的一次性平台等發展正在將SUT的應用範圍從早期階段擴展到商業規模。產業主要企業也在投資結合一次性系統和不銹鋼系統的混合生物製程模式，以平衡成本、規模和合規性。這一趨勢反映了製造商不斷變化的需求，即根據批次大小、產品類型和監管要求客製化生產環境。

展望未來，美國生物加工市場中一次性使用系統 (SUT) 的成長軌跡得益於強力的監管認可、對彈性生產設施的不斷投資以及不斷擴展的生技藥品和先進療法產品線。該技術能夠降低資本支出、營運風險和生產停機時間，這對於下一代生物製造至關重要。隨著產業持續優先考慮速度、安全性和可擴展性，一次性系統預計將在塑造美國生物加工的未來方面發揮更核心的作用。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國大規模和小規模生物加工市場的變數和趨勢

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國大規模與小規模生物加工市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國大規模和小規模生物加工市場：規模、估值和趨勢分析

  • 尺寸細分儀表板
  • 美國大規模與小規模生物加工市場規模變化分析
  • 美國大規模及小規模生物加工市場規模及趨勢分析（依規模，2021-2033）
  • 工業規模（5萬公升以上）
  • 小規模（小於50,000公升）

第5章美國大規模與小規模生物加工市場：依工作流程估算與趨勢分析

  • 工作細分儀表板
  • 美國大規模和小規模生物加工市場的工作流程變化分析
  • 美國大規模及小規模生物加工市場規模及趨勢分析（按工作流程，2021-2033）
  • 下游加工
  • 發酵
  • 上游處理

第6章：美國大規模和小規模生物加工市場（按產品、估算和趨勢分析）

  • 產品細分儀表板
  • 美國大規模和小規模生物加工市場的產品差異分析
  • 美國大規模和小規模生物加工市場規模和趨勢分析（按產品，2021-2033 年）
  • 反應器/發酵罐
  • 細胞培養產品
  • 過濾組件
  • 反應器配件
  • 袋子和容器
  • 其他

第7章：美國大規模和小規模生物加工市場的應用、估計和趨勢分析

  • 應用程式細分儀表板
  • 美國大規模和小規模生物加工市場應用變化分析
  • 美國大規模和小規模生物加工市場規模和趨勢分析（按應用，2021-2033 年）
  • 生物製藥
  • 特種工業化學品
  • 環境援助

第 8 章：美國大規模和小規模生物加工市場（按用途類型、估計和趨勢分析）

  • 使用類型細分儀表板
  • 美國大規模和小規模生物加工市場使用類型變化分析
  • 美國大規模和小規模生物加工市場規模和趨勢分析（按用途類型，2021-2033 年）
  • 多才多藝的
  • 一次性的

第9章美國大規模和小規模生物加工市場（按模式、估計和趨勢分析）

  • 模式細分儀表板
  • 美國大規模和小規模生物加工市場的模式變異分析
  • 美國大規模及小規模生物加工市場規模及趨勢分析（按模式）（2021-2033）
  • 內部
  • 外包

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • Corning Inc.
    • Sartorius AG
    • Lonza
    • Eppendorf AG
    • Getinge AB
    • PBS BIoTech, Inc.
    • Meissner Filtration Products, Inc.
    • Entegris
    • Saint-Gobain
    • Repligen Corporation
    • Avantor, Inc
    • Distek, Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Synthesis, Inc.
Product Code: GVR-4-68040-671-2

U.S. Large And Small-scale Bioprocessing Market Summary

The U.S. large and small-scale bioprocessing market size was estimated at USD 24.86 billion in 2024 and is projected to reach USD 67.34 billion by 2033, growing at a CAGR of 11.24% from 2025 to 2033. This growth is driven by the rising global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.

Biopharmaceutical companies are increasingly investing in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, to accelerate development timelines and reduce costs.

Growing Adoption of Single-Use Technologies in U.S. Bioprocessing

The increasing implementation of single-use technology (SUT) is transforming the U.S. large- and small-scale bioprocessing market, enabling greater flexibility, operational efficiency, and cost-effectiveness in biologics manufacturing. Single-use systems, including bioreactors, bags, filters, connectors, and tubing, are increasingly favored over traditional stainless-steel setups, particularly for small-batch and multiproduct facilities. Their ability to reduce cleaning validation, lower the risk of cross-contamination, and minimize turnaround times makes them highly suitable for modern, fast-paced bioproduction environments. As the demand for personalized medicine and modular manufacturing grows, SUT adoption is accelerating across both clinical and commercial stages.

Biopharmaceutical companies and CDMOs are leveraging single-use technologies to streamline scale-up processes, shorten development timelines, and meet the increasing need for agile production. These systems are particularly valuable in early-stage manufacturing, where flexibility and speed are critical. The growth of cell and gene therapies, which often require small, high-value batches, is further driving the shift toward SUT-based infrastructure. Additionally, the rise of multiproduct facilities demands rapid changeovers, which are more efficiently supported by single-use components than traditional clean-in-place systems.

Manufacturers of bioprocessing equipment are continuously innovating within the SUT space to enhance performance, durability, and compatibility with complex biologics. Developments such as gamma-stable polymers, automation-integrated systems, and scalable single-use platforms are expanding the applicability of SUTs beyond early-stage production to include commercial-scale operations. Key industry players are also investing in hybrid bioprocessing models, combining single-use and stainless-steel systems, to balance cost, scale, and compliance. This trend reflects the evolving needs of manufacturers to customize production environments based on batch size, product type, and regulatory requirements.

Looking ahead, the growth trajectory of SUT in the U.S. bioprocessing market is supported by strong regulatory acceptance, increasing investment in flexible manufacturing facilities, and the expanding pipeline of biologics and advanced therapies. The technology's ability to reduce capital expenditure, operational risk, and production downtime positions it as a core enabler of next-generation biomanufacturing. As the industry continues to prioritize speed, safety, and scalability, single-use systems are expected to play an even more central role in shaping the future of bioprocessing in the U.S.

U.S. Large And Small-Scale Bioprocessing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. large and small-scale bioprocessing market based on scale, workflow, product, application, use-type, and mode:

  • Scale Outlook (Revenue, USD Million, 2021 - 2033)
  • Industrial Scale (Over 50,000 Liter)
  • Small Scale (Less Than 50,000 Liter)
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Downstream Processing
  • Fermentation
  • Upstream Processing
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filtration Assemblies
  • Bioreactors Accessories
  • Bags & Containers
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceuticals
  • Speciality Industrial Chemicals
  • Environmental Aids
  • Use-Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Multi-Use
  • Single-Use
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • In-House
  • Outsourced

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Scale Segment
    • 1.2.2. Workflow Segment
    • 1.2.3. Product Segment
    • 1.2.4. Application Segment
    • 1.2.5. Use-type Segment
    • 1.2.6. Mode Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Large and Small-scale Bioprocessing Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing implementation of single-use technology for bioproduction
      • 3.2.1.2. Rising demand for biologics
      • 3.2.1.3. Expansion of contract development and manufacturing organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
      • 3.2.2.2. Complexity and regulatory hurdles
  • 3.3. U.S. Large and Small-scale Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Large and Small-scale Bioprocessing Market: Scale Estimates & Trend Analysis

  • 4.1. Scale Segment Dashboard
  • 4.2. U.S. Large and Small-scale Bioprocessing Market Scale Movement Analysis
  • 4.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
  • 4.4. Industrial Scale (Over 50,000 Liter)
    • 4.4.1. Industrial scale (Over 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Small Scale (Less Than 50,000 Liter)
    • 4.5.1. Small scale (Less Than 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Large and Small-scale Bioprocessing Market: Workflow Estimates & Trend Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. U.S. Large and Small-scale Bioprocessing Market Workflow Movement Analysis
  • 5.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
  • 5.4. Downstream Processing
    • 5.4.1. Downstream processing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Fermentation
    • 5.5.1. Fermentation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Upstream Processing
    • 5.6.1. Upstream processing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Large and Small-scale Bioprocessing Market: Product Estimates & Trend Analysis

  • 6.1. Product Segment Dashboard
  • 6.2. U.S. Large and Small-scale Bioprocessing Market Product Movement Analysis
  • 6.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 6.4. Bioreactors/Fermenters
    • 6.4.1. Bioreactors/fermenters market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Cell Culture Products
    • 6.5.1. Cell culture products market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Filtration Assemblies
    • 6.6.1. Filtration assemblies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Bioreactors Accessories
    • 6.7.1. Bioreactors accessories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Bags & Containers
    • 6.8.1. Bags & containers market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Large and Small-scale Bioprocessing Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. U.S. Large and Small-scale Bioprocessing Market Application Movement Analysis
  • 7.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Biopharmaceuticals
    • 7.4.1. Biopharmaceuticals market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Speciality Industrial Chemicals
    • 7.5.1. Speciality industrial chemicals market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Environmental Aids
    • 7.6.1. Environmental aids market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. U.S. Large and Small-scale Bioprocessing Market: Use-Type Estimates & Trend Analysis

  • 8.1. Use-Type Segment Dashboard
  • 8.2. U.S. Large and Small-scale Bioprocessing Market Use-Type Movement Analysis
  • 8.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Use-Type, 2021 to 2033 (USD Million)
  • 8.4. Multi-use
    • 8.4.1. Multi-use market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Single-use
    • 8.5.1. Single-use market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. U.S. Large and Small-scale Bioprocessing Market: Mode Estimates & Trend Analysis

  • 9.1. Mode Segment Dashboard
  • 9.2. U.S. Large and Small-scale Bioprocessing Market Mode Movement Analysis
  • 9.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 9.4. In-house
    • 9.4.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Outsourced
    • 9.5.1. Outsourced market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Danaher
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Corning Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Sartorius AG
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Lonza
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Eppendorf AG
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Getinge AB
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. PBS Biotech, Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Meissner Filtration Products, Inc.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Entegris
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Saint-Gobain
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Repligen Corporation
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Avantor, Inc
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Distek, Inc.
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. F. Hoffmann-La Roche Ltd
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. Bio-Synthesis, Inc.
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 U.S. Large and Small-Scale Bioprocessing Market, By Scale, 2021 - 2033 (USD Million)
  • Table 3 U.S. Large and Small-Scale Bioprocessing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 4 U.S. Large and Small-Scale Bioprocessing Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Large and Small-Scale Bioprocessing Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Large and Small-Scale Bioprocessing Market, By Use-Type, 2021 - 2033 (USD Million)
  • Table 7 U.S. Large and Small-Scale Bioprocessing Market, By Mode, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. large and small-scale bioprocessing market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. large and small-scale bioprocessing market: Scale outlook key takeaways
  • Fig. 13 U.S. large and small-scale bioprocessing market: Scale movement analysis
  • Fig. 14 Industrial scale market, 2021 - 2033 (USD Million)
  • Fig. 15 Small scale market, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. large and small-scale bioprocessing market: Workflow outlook key takeaways
  • Fig. 17 U.S. large and small-scale bioprocessing market: Workflow movement analysis
  • Fig. 18 Downstream processing market, 2021 - 2033 (USD Million)
  • Fig. 19 Fermentation market, 2021 - 2033 (USD Million)
  • Fig. 20 Upstream processing market, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. large and small-scale bioprocessing market: Product outlook key takeaways
  • Fig. 22 U.S. large and small-scale bioprocessing market: Product movement analysis
  • Fig. 23 Bioreactors/fermenters market, 2021 - 2033 (USD Million)
  • Fig. 24 Cell culture products market, 2021 - 2033 (USD Million)
  • Fig. 25 Filtration assemblies market, 2021 - 2033 (USD Million)
  • Fig. 26 Bioreactors accessories market, 2021 - 2033 (USD Million)
  • Fig. 27 Bags & containers market, 2021 - 2033 (USD Million)
  • Fig. 28 Others market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. large and small-scale bioprocessing market: Application outlook and key takeaways
  • Fig. 30 U.S. large and small-scale bioprocessing market: Application movement analysis
  • Fig. 31 Biopharmaceuticals market, 2021 - 2033 (USD Million)
  • Fig. 32 Speciality industrial chemicals market, 2021 - 2033 (USD Million)
  • Fig. 33 Environmental aids market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. large and small-scale bioprocessing market: Mode outlook key takeaways
  • Fig. 35 U.S. large and small-scale bioprocessing market: Mode movement analysis
  • Fig. 36 In-house market, 2021 - 2033 (USD Million)
  • Fig. 37 Outsourced market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. large and small-scale bioprocessing market: Use-type outlook key takeaways
  • Fig. 39 U.S. large and small-scale bioprocessing market: Use-type movement analysis
  • Fig. 40 Multi-use market, 2021 - 2033 (USD Million)
  • Fig. 41 Single-use market, 2021 - 2033 (USD Million)